ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

BTTX Better Therapeutics Inc

0.0446
0.00 (0.00%)
02 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Better Therapeutics Inc BTTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 0.0446 09:00:00
개장가 저가 고가 종가 전일 종가
0.0446 0.0446
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
14/03/202422:38BWBetter Therapeutics Announces it will Seek Strategic..
11/03/202422:01EDGAR2Form 8-K - Current report
05/03/202423:25BWBetter Therapeutics Announces an Innovative Partnership with..
04/03/202423:25BWBetter Therapeutics Announces Acceptance of Late Breaking..
04/03/202422:51EDGAR2Form 8-K - Current report
01/03/202420:08EDGAR2Form RW - Registration Withdrawal Request
20/02/202423:25BWBetter Therapeutics Receives FDA Breakthrough Device..
13/02/202406:28EDGAR2Form SC 13D/A - General statement of acquisition of..
06/02/202423:43BWBetter Therapeutics Signs Rebate Agreement with One of the..
06/02/202423:02EDGAR2Form S-1/A - General form for registration of securities..
26/01/202406:30EDGAR2Form SC 13D/A - General statement of acquisition of..
24/01/202407:22EDGAR2Form D - Notice of Exempt Offering of Securities
17/01/202423:28BWBetter Therapeutics Announces Publication of..
10/01/202421:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/01/202406:42EDGAR2Form 8-K - Current report
05/01/202404:00BWBetter Therapeutics and Glooko Announce Partnership to..
02/01/202421:45BWBetter Therapeutics Announces Submission for FDA..
29/12/202311:23EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/12/202307:21EDGAR2Form S-1/A - General form for registration of securities..
21/12/202307:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202307:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202307:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202307:24EDGAR2Form S-1 - General form for registration of securities under..
14/12/202307:06EDGAR2Form 8-K - Current report
08/12/202310:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/12/202306:10EDGAR2Form 8-K - Current report
28/11/202321:45BWBetter Therapeutics Strengthens Financial Position Through..
21/11/202307:08EDGAR2Form 8-K - Current report
14/11/202321:00BWFrost & Sullivan Honors Better Therapeutics with the 2023..
09/11/202321:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202321:03EDGAR2Form 8-K - Current report
09/11/202321:00BWBetter Therapeutics Reports Third Quarter 2023 Financial..
08/11/202321:30BWBetter Therapeutics to Release Third Quarter 2023 Financial..
31/10/202305:14EDGAR2Form 8-K - Current report
28/10/202305:26EDGAR2Form S-1/A - General form for registration of securities..
26/10/202320:55BWBetter Therapeutics to Participate in the American College..
16/10/202320:55BWBetter Therapeutics Announces Launch of AspyreRxTM to Treat..
16/10/202320:22EDGAR2Form DEF 14A - Other definitive proxy statements
13/10/202305:17EDGAR2Form S-3/A - Registration statement under Securities Act of..
11/10/202320:55BWBetter Therapeutics Announces New Data Highlighting..
07/10/202305:15EDGAR2Form PRE 14A - Other preliminary proxy statements
05/10/202320:45BWBetter Therapeutics Announces Publication of LivVita Liver..
29/09/202305:16BWBetter Therapeutics Completes Enrollment in Real-World..
26/08/202305:26EDGAR2Form S-3/A - Registration statement under Securities Act of..
15/08/202305:02EDGAR2Form SC 13D/A - General statement of acquisition of..
10/08/202305:37EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/08/202305:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202305:07EDGAR2Form 8-K - Current report
10/08/202305:03BWBetter Therapeutics Reports Second Quarter 2023 Financial..
03/08/202306:30BWBetter Therapeutics to Release Second Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock